Related references
Note: Only part of the references are listed.Pathophysiology of atrial fibrillation and chronic kidney disease
Wern Yew Ding et al.
CARDIOVASCULAR RESEARCH (2021)
Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study
Emma Kirstine Laugesen et al.
THROMBOSIS JOURNAL (2019)
Real-world Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medica Records
Hun-Sung Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2018)
Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the Real-World Michigan Anticoagulation Quality Improvement Initiative (MAQI2) registry to the RE-LY, ROCKET-AF, and ARISTOTLE trials
Andrew B. Hughey et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2018)
A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the Real-World vs Clinical Trials
Jose Miguel Rivera-Caravaca et al.
MAYO CLINIC PROCEEDINGS (2018)
Catheter Ablation for Atrial Fibrillation with Heart Failure
Nassir F. Marrouche et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study
Simone Y. Loo et al.
BMJ OPEN (2018)
Strengths and weaknesses of 'realworld' studies involving non-vitamin K antagonist oral anticoagulants
A. John Camm et al.
OPEN HEART (2018)
Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban
A. John Camm et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Outcomes with Dronedarone in Atrial Fibrillation: What Differences Between Real-World Practice and Trials? A Meta-Analysis and Meta-Regression Analysis
Igor Diemberger et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial
Erin A. Bohula et al.
CIRCULATION (2016)
The Risk of Major Hemorrhage with CKD
Amber O. Molnar et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Unreal world or real world data in oral anticoagulant treatment of atrial fibrillation
Ben Freedman et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease
Judith Kooiman et al.
PLOS ONE (2014)
The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments
Peter C. Austin
STATISTICS IN MEDICINE (2014)
Renal Impairment in a Real-Life Cohort of Anticoagulated Patients With Atrial Fibrillation (Implications for Thromboembolism and Bleeding)
Vanessa Roldan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Conflicts of interest in biomedical publications: considerations for authors, peer reviewers, and editors
Armen Yuri Gasparyan et al.
CROATIAN MEDICAL JOURNAL (2013)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research
Nick Freemantle et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
Stefan H. Hohnloser et al.
EUROPEAN HEART JOURNAL (2012)
Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis
Deborah Zimmerman et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
Jonas Bjerring Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database
Sally Lee et al.
BMJ OPEN (2012)
Problems of stopping trials early
Gordon H. Guyatt et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
Peter C. Austin
PHARMACEUTICAL STATISTICS (2011)
Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects Systematic Review and Meta-regression Analysis
Dirk Bassler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Low glomerular filtration rate and risk of stroke: meta-analysis
Meng Lee et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
Peter C. Austin
STATISTICS IN MEDICINE (2009)
Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial
LANCET (2008)
Using real-world data for coverage and payment decisions: The ISPOR real-world data task force report
Louis P. Garrison et al.
VALUE IN HEALTH (2007)
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Robert G. Hart et al.
ANNALS OF INTERNAL MEDICINE (2007)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study
S Stewart et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Share Paper
